Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer with Magnetic Resonance Imaging
Adult
Aged, 80 and over
Male
Rectal Neoplasms
Chemoradiotherapy, Adjuvant
Middle Aged
Magnetic Resonance Imaging
Sensitivity and Specificity
Neoadjuvant Therapy
Tumor Burden
3. Good health
03 medical and health sciences
0302 clinical medicine
Lymphatic Metastasis
Humans
Female
Lymph Nodes
Postoperative Period
Aged
Neoplasm Staging
DOI:
10.1007/s11605-017-3568-x
Publication Date:
2017-09-12T17:48:44Z
AUTHORS (5)
ABSTRACT
The accuracy of pretherapeutic staging of lymph nodes (LN) in rectal cancer by MR imaging (MRI) is still limited. The aim of the study was to determine the sensitivity and specificity of different morphological criteria in nodal staging.LN were analyzed by MRI in 60 patients with rectal cancer and primary surgery. Signs of LN metastasis (cN+) were spiculated/indistinct border contour, inhomogeneous signal intensity, or LN size. The accuracy of these signs for clinical LN staging was analyzed with conclusive postoperative histological lymph node examination.68.3% of patients with nodal metastasis (pN+) were correctly identified by size with a cutoff value of 7.2 mm. This, however, was not inferior to the 76.7% identified using the inhomogeneous morphological signal intensity and spiculated/indistinct border contour criteria (p = 0.096). 3.3 versus 5% were overstaged, and 28.3 versus 18.3% understaged by these criteria. Sensitivities/specificities for (a) size, (b) spiculated/indistinct border contour, and (c) inhomogeneous signal intensity and spiculated/indistinct border contour were (a) 32%/94%, (b) 56%/86%, and (c) 56%/91%, respectively.The accuracy of LN staging in rectal cancer was not improved by morphological criteria. These limitations suggest being reticent when recommending neoadjuvant chemoradiation merely based on preoperative positive LN staging.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (71)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....